Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma.

scientific article published on July 2007

Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/CNCR.22759
P698PubMed publication ID17508408
P5875ResearchGate publication ID6324858

P50authorHyun Woong LeeQ57321514
Jun Yong ParkQ58221011
Sang Hoon AhnQ63436666
Kwang-Hyub HanQ63436668
Young Joon YoonQ83971708
Chae Yoon ChonQ114727137
Young Myoung MoonQ114727155
P2093author name stringDo Yun Lee
Ja Kyung Kim
P2860cites workGlobal cancer statistics, 2002Q27860562
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the LiverQ29616866
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 casesQ33344056
Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-fu and interferon-alpha-2bQ33489279
Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trialsQ34068152
Prognostic prediction and treatment strategy in hepatocellular carcinoma.Q34547469
Treatment of non-resectable hepatocellular carcinomaQ35020886
Treatment outcome of transcatheter arterial chemoinfusion according to anticancer agents and prognostic factors in patients with advanced hepatocellular carcinoma (TNM stage IVa).Q38516034
Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patientsQ43850818
Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal veinQ44062778
Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapyQ44232425
Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?Q51815043
Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pumpQ67531478
A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal veinQ73335123
Intermittent hepatic arterial infusion of high-dose 5FU on a weekly schedule for liver metastases from colorectal cancerQ73793465
Efficacy of an implanted drug delivery system for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin CQ78246167
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectfluorouracilQ238512
cisplatinQ412415
chemotherapyQ974135
P304page(s)129-137
P577publication date2007-07-01
P1433published inCancerQ326041
P1476titleRepetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma
P478volume110

Reverse relations

cites work (P2860)
Q87401733A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
Q35833016A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma
Q44681461A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy
Q53399296Adjuvant hepatic arterial infusional chemotherapy with 5-fluorouracil and cisplatin after curative resection of hepatocellular carcinoma.
Q45358377Antiviral efficacy of lamivudine versus entecavir in patients with hepatitis B virus-related advanced hepatocellular carcinoma.
Q53379427Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma.
Q42332098Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
Q90366618Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score-matched survival analysis
Q47775953Chemotherapy for hepatocellular carcinoma: current status and future perspectives
Q89750132Clinical effects and safety of intra-arterial infusion therapy of cisplatin suspension in lipiodol combined with 5-fluorouracil versus sorafenib, for advanced hepatocellular carcinoma with macroscopic vascular invasion without extra-hepatic spread:
Q53356745Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis.
Q43485596Conditional survival estimate in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy with/without concurrent radiotherapy.
Q38032906Current status of hepatocellular carcinoma treatment in Japan: hepatic arterial infusion chemotherapy
Q57292656Cytotoxicity and Toxicity Evaluation of Xanthone Crude Extract on Hypoxic Human Hepatocellular Carcinoma and Zebrafish () Embryos
Q35553137Different survival of Barcelona clinic liver cancer stage C hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spread
Q37039311Doxorubicin and 5-fluorouracil resistant hepatic cancer cells demonstrate stem-like properties
Q35890647Efficacy and safety of metronomic chemotherapy for patients with advanced primary hepatocellular carcinoma with major portal vein tumor thrombosis
Q35025403Efficacy of sorafenib monotherapy versus sorafenib-based loco-regional treatments in advanced hepatocellular carcinoma
Q53289466Evaluation of ERCC1 Expression for Cisplatin Sensitivity in Human Hepatocellular Carcinoma
Q34390215Future perspectives on the treatment of hepatocellular carcinoma with cisplatin
Q38161384Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in Japan
Q37068236Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis
Q38410821Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma
Q33404756Hepatic intra-arterial chemotherapy in patients with advanced primary liver tumours
Q51842347How to improve treatment outcomes for hepatocellular carcinoma of intermediate and advanced stage.
Q53038960Intra-arterial chemotherapy with doxorubicin and cisplatin is effective for advanced hepatocellular cell carcinoma.
Q37124855Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy.
Q39863380Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma.
Q36738649Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma
Q26797643Multimodality Management for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma
Q97539487Neoadjuvant therapy and immunotherapy strategies for hepatocellular carcinoma
Q64987573Network meta-analysis of treatment regimens for inoperable advanced hepatocellular carcinoma with portal vein invasion.
Q41316719Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma
Q90288434Patients with Barcelona Clinic Liver Cancer Stages B and C Hepatocellular Carcinoma: Time for a Subclassification
Q48256935Phase II Study of Sorafenib Combined with Concurrent Hepatic Arterial Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin for Unresectable Hepatocellular Carcinoma with Major Portal Vein Thrombosis
Q46491963Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis
Q37972806Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Q36791086Primary extraosseous Ewing sarcoma of the lung in children
Q45369097Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan).
Q92643831Role and limitation of neoadjuvant hepatic arterial infusion chemotherapy in advanced hepatocelluar carcinoma patients with Child-Pugh class A
Q53172824Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy.
Q91879742Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion: A Randomized Clinical Trial
Q36230740Sorafenib and hepatic arterial infusion chemotherapy for unresectable advanced hepatocellular carcinoma: A comparative study
Q33379418Systemic gemcitabine combined with intra-arterial low-dose cisplatin and 5-fluorouracil for advanced hepatocellular carcinoma: seven cases
Q53466176Systemic treatment in advanced/metastatic hepatocellular carcinoma in the era of targeted therapy.
Q43897398Therapeutic benefit of radiotherapy in huge (≥10 cm) unresectable hepatocellular carcinoma
Q26772299Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review
Q42580930Which treatment modality should we choose for advanced hepatocellular carcinoma?

Search more.